Healthy, active, no family history
Maya is 34, an entrepreneur in San Francisco, and exercises three times a week. Her last physical came back with the line most people get: "Cholesterol looks fine, see you next year."

Maya, 34
- LDL-C118 mg/dL
- hsCRP0.6 mg/L
- HbA1c5.2%
Not on a typical panel
- ApoB98 mg/dL
- Lp(a)12 nmol/L
- FH variantsNone
- Coronary disease PRS93rd pct
Her genome puts her in the top 7% for heart disease risk
Maya's polygenic risk score for coronary disease, a number built from thousands of inherited variants, came back high.
She carries about three times the coronary disease risk of everyone else, the same risk as if she had familial hypercholesterolemia, a condition that doctors treat early and aggressively.1
Lower risk
Average
Higher risk
Every year of high LDL adds up
Standard Target< 130
118mg/dL
Lab report flags nothing.
“Cholesterol looks fine”
High genetic risk responds most to lowering LDL
Beyond the guideline. Backed by the evidence.
| Category | Who qualifies under the guideline | LDL Goal |
|---|---|---|
| Normal | A low 10-year risk score | under 130a |
| Borderline / Intermediate risk | An elevated 10-year risk score | under 100b |
| High risk | Familial hypercholesterolemia, a single-gene condition | under 70b |
a The top of a typical lab reference range.b 2026 ACC/AHA dyslipidemia guideline.6
Clear next steps
Maya's SONATA doctor walks her through the plan, explains her genetic risk and what her biomarkers mean, and prescribes what she needs.
Priority 1
A daily statin
- adjustRosuvastatin 10mg1 capsule daily
Her doctor prescribes rosuvastatin 10 mg, taken daily. Expected to lower her LDL by about 45%, from 118 to the mid 60s.
Priority 2
A shift in diet
- continueModified Mediterranean DietNutrition
A Mediterranean diet is recommended. It's associated with about half the cardiovascular risk over 30 years.7
Ongoing
A care plan that evolves with her
- At six months, she retests. LDL and ApoB to see whether the statin is working, liver and muscle enzymes to check it isn't causing side effects.
- If her LDL is still above 70, her doctor adds ezetimibe.
- If she wants a closer look, her doctor can order a coronary calcium scan earlier than guidelines call for.
Found at 34. Half the risk of a heart attack or stroke by 64.
With SONATA, Maya avoids about 1,500 mg/dL-years of exposure by age 64. Based on population data, that difference corresponds to roughly half the risk of a heart attack or stroke.5

~50%
lower cardiovascular risk by age 64
Derived from Domanski et al., JACC 20205

